HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lower-dose thalidomide therapy effectively treats cutaneous lupus erythematosus but is limited by neuropathic toxicity.

AuthorsHillary C Frankel, Victoria R Sharon, Ruth Ann Vleugels, Joseph F Merola, Abrar A Qureshi
JournalInternational journal of dermatology (Int J Dermatol) Vol. 52 Issue 11 Pg. 1407-9 (Nov 2013) ISSN: 1365-4632 [Electronic] England
PMID24164159 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunosuppressive Agents
  • Thalidomide
Topics
  • Adult
  • Aged
  • Female
  • Humans
  • Immunosuppressive Agents (administration & dosage, adverse effects)
  • Lupus Erythematosus, Discoid (drug therapy)
  • Male
  • Middle Aged
  • Paresthesia (chemically induced)
  • Recurrence
  • Retrospective Studies
  • Thalidomide (administration & dosage, adverse effects)
  • Withholding Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: